Archives for September 29, 2022

← 2022
GSK picks up antibiotic in $66m deal

GSK picks up antibiotic in $66m deal

By Ben Hargreaves

GSK pays for the exclusive license of Spero‘s late-stage antibiotic to potentially treat complicated urinary tract infections.